271 views | 2 years ago
El Perfil Genómico Integral (PGI) del ADN tumoral circulante (ctDNA) obtenido mediante biopsia líquida sanguínea proporciona resultados importantes para informar la selección de terapias posteriores....
1626 views | 2 years ago
Comprehensive Genomic Profiling (CGP) of circulating tumor DNA (ctDNA) from blood liquid biopsy provides important results to inform subsequent therapy selection. In this video interview, Dr. Atocha...
94709 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1143 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
379 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
230 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1082 views | 2 years ago
This video shows the value of connecting your Illumina instrument to Illumina Proactive, a transformative program that brings enhanced service, support, and lab management capabilities to your lab....
1491 views | 2 years ago
During ESMO 2023 in Madrid, Illumina customers speak about the importance of WGS and CGP in their practice. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc...